Center for Genomics and Systems Biology, Department of Biology, New York University, New York, New York.
Department of Epidemiology, School of Global Public Health, New York University, New York, New York.
Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):97-106. doi: 10.4269/ajtmh.21-1333.
The Center for the Study of Complex Malaria in India (CSCMi) is one of 10 International Centers of Excellence in Malaria Research funded by the National Institutes of Health since 2010. The Center combines innovative research with capacity building and technology transfer to undertake studies with clinical and translational impact that will move malaria control in India toward the ultimate goal of malaria elimination/eradication. A key element of each research site in the four states of India (Tamil Nadu, Gujarat, Odisha, and Meghalaya) has been undertaking community- and clinic-based epidemiology projects to characterize the burden of malaria in the region. Demographic and clinical data and samples collected during these studies have been used in downstream projects on, for example, the widespread use of mosquito repellants, the population genomics of Plasmodium vivax, and the serological responses to P. vivax and Plasmodium falciparum antigens that reflect past or present exposure. A focus has been studying the pathogenesis of severe malaria caused by P. falciparum through magnetic resonance imaging of cerebral malaria patients. Here we provide a snapshot of some of the basic and applied research the CSCMi has undertaken over the past 12 years and indicate the further research and/or clinical and translational impact these studies have had.
印度复杂疟疾研究中心(CSCMi)是自 2010 年以来,美国国立卫生研究院资助的 10 个疟疾研究卓越国际中心之一。该中心将创新性研究与能力建设和技术转让相结合,开展具有临床和转化影响的研究,推动印度的疟疾控制朝着消除/消灭疟疾的最终目标迈进。该中心在印度四个邦(泰米尔纳德邦、古吉拉特邦、奥里萨邦和梅加拉亚邦)的每个研究地点的一个关键要素是开展基于社区和诊所的流行病学项目,以确定该地区疟疾的负担。在这些研究中收集的人口统计学和临床数据和样本已用于下游项目,例如,广泛使用驱蚊剂、间日疟原虫的种群基因组学以及对间日疟原虫和恶性疟原虫抗原的血清学反应,这些反应反映了过去或现在的暴露情况。该中心的一个重点是通过对脑型疟疾患者进行磁共振成像来研究由恶性疟原虫引起的严重疟疾的发病机制。在这里,我们提供了 CSCMi 在过去 12 年中进行的一些基础和应用研究的快照,并指出了这些研究的进一步研究和/或临床和转化影响。